![]() Epirubicin hydrochloride structure
|
Common Name | Epirubicin hydrochloride | ||
---|---|---|---|---|
CAS Number | 56390-09-1 | Molecular Weight | 579.980 | |
Density | 1.61g/cm3 | Boiling Point | 810.3ºC at 760 mmHg | |
Molecular Formula | C27H30ClNO11 | Melting Point | 185ºC dec | |
MSDS | N/A | Flash Point | 443.8ºC | |
Symbol |
![]() ![]() GHS07, GHS08 |
Signal Word | Danger |
Fourier transform infrared spectroscopy imaging of live epithelial cancer cells under non-aqueous media.
J. Clin. Pathol. 66(4) , 312-8, (2013) Fourier transform infrared (FT-IR) imaging is increasingly being applied to biomedical specimens, but strong IR absorption by water complicates live cell imaging. This study investigates the viability of adherent epithelial cells maintained for short periods ... |
|
Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature.
Tumori 99(2) , e65-9, (2013) Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that originates from follicular dendritic cells in lymphoid follicles. FDCS has been increasingly reported in recent years. However, data on FDCS are mostly based on single case reports or case serie... |
|
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Br. J. Haematol. 165(4) , 534-44, (2014) The purpose of this national retrospective study was to evaluate the outcome in children with relapsed or primary refractory Hodgkin lymphoma [HL] after a primary chemotherapy alone treatment strategy. Between 2000 and 2005, 80 children with relapsed [n = 69]... |
|
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
BMC Cancer 13 , 56, (2013) Several GI peptides linked to intestinal barrier function could be involved in the modification of intestinal permeability and the onset of diarrhea during adjuvant chemotherapy. The aim of the study was to evaluate the circulating levels of zonulin, glucagon... |
|
Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites.
Anticancer Drugs 24(4) , 375-83, (2013) The in-vitro growth inhibition of cancer and normal cell lines caused by mixed or covalently linked antimetabolites should clarify whether the conjugation of antimetabolites influences cell sensitivity and growth inhibition in a manner that differs from an eq... |
|
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Eur. J. Surg. Oncol. 41(1) , 94-9, (2015) The impact of neoadjuvant chemotherapy (NACT) on immediate free flap breast reconstruction remains controversial. Furthermore, the oncological outcomes of immediate free flap breast reconstruction after skin-sparing mastectomy (SSM) following NACT remain uncl... |
|
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients with Post-radiation Persistently Detectable Plasma EBV DNA
Int. J. Radiat. Oncol. Biol. Phys. 89(1) , 21-9, (2014) Purpose To investigate the effects of adjuvant chemotherapy in nasopharyngeal carcinoma (NPC) patients with persistently detectable plasma Epstein-Barr virus DNA (pEBV DNA) after curative radiotherapy plus induction/concurrent chemotherapy. |
|
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.
J. Natl. Cancer Inst. 106(1) , djt335, (2014) There is no method routinely used to predict response to anthracycline and cyclophosphamide-based chemotherapy in the clinic; therefore patients often receive treatment for breast cancer with no benefit. Loss of the Fanconi anemia/BRCA (FA/BRCA) DNA damage re... |
|
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
J. Clin. Oncol. 32(34) , 3848-57, (2014) The presence of disseminated tumor cells (DTCs) in bone marrow (BM) predicts survival in early breast cancer. This study explores the use of DTCs for identification of patients insufficiently treated with adjuvant therapy so they can be offered secondary adju... |
|
The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
J. Cancer Res. Clin. Oncol. 140(10) , 1777-82, (2014) Preoperative or neoadjuvant chemotherapy is an option in patients with large operable breast cancer to facilitate the breast conservation and to downstage the disease to make inoperable breast cancer to operable one. It is also called the window of opportunit... |